Menu
GWAS Study

Identification of four novel associations for B-cell acute lymphoblastic leukaemia risk.

Vijayakrishnan J, Qian M, Studd JB et al.

31767839 PubMed ID
GWAS Study Type
27685 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

VJ
Vijayakrishnan J
QM
Qian M
SJ
Studd JB
YW
Yang W
KB
Kinnersley B
LP
Law PJ
BP
Broderick P
RE
Raetz EA
AJ
Allan J
PC
Pui CH
VA
Vora A
EW
Evans WE
MA
Moorman A
YA
Yeoh A
YW
Yang W
LC
Li C
BC
Bartram CR
MC
Mullighan CG
ZM
Zimmerman M
HS
Hunger SP
SM
Schrappe M
RM
Relling MV
SM
Stanulla M
LM
Loh ML
HR
Houlston RS
YJ
Yang JJ
Chapter II

Abstract

Summary of the research findings

There is increasing evidence for a strong inherited genetic basis of susceptibility to acute lymphoblastic leukaemia (ALL) in children. To identify new risk variants for B-cell ALL (B-ALL) we conducted a meta-analysis with four GWAS (genome-wide association studies), totalling 5321 cases and 16,666 controls of European descent. We herein describe novel risk loci for B-ALL at 9q21.31 (rs76925697, P = 2.11 × 10-8), for high-hyperdiploid ALL at 5q31.1 (rs886285, P = 1.56 × 10-8) and 6p21.31 (rs210143 in BAK1, P = 2.21 × 10-8), and ETV6-RUNX1 ALL at 17q21.32 (rs10853104 in IGF2BP1, P = 1.82 × 10-8). Particularly notable are the pleiotropic effects of the BAK1 variant on multiple haematological malignancies and specific effects of IGF2BP1 on ETV6-RUNX1 ALL evidenced by both germline and somatic genomic analyses. Integration of GWAS signals with transcriptomic/epigenomic profiling and 3D chromatin interaction data for these leukaemia risk loci suggests deregulation of B-cell development and the cell cycle as central mechanisms governing genetic susceptibility to ALL.

5,321 European ancestry cases, 16,666 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

27685
Total Participants
GWAS
Study Type
Yes
Replicated
2,237 cases, 3,461 controls
Replication Participants
European
Ancestry
Germany, U.K.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.